Search Results - "López‐Díaz de Cerio, Ascensión"

MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells by Soldevilla, Mario Martínez, Villanueva, Helena, Casares, Noelia, Lasarte, Juan Jose, Bendandi, Maurizio, Inoges, Susana, López-Díaz de Cerio, Ascensión, Pastor, Fernando

“…In this work we show a clinically feasible strategy to convert in situ the own tumor into an endogenous vaccine by coating the melanoma cancerous cells with…”
Get full text

Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma by Casales, Erkuden, Martisova, Eva, Villanueva, Helena, de Cerio, Ascensión López Díaz, Inoges, Susana, Silva-Pilipich, Noelia, Ballesteros-Briones, María Cristina, Aranda, Alejandro, Bezunartea, Jaione, Bendandi, Maurizio, Pastor, Fernando, Smerdou, Cristian

“…A promising therapy for patients with B-cell lymphoma is based on vaccination with idiotype monoclonal antibodies (mAbs). Since idiotypes are different in each…”
Get full text

Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model‐based characterization approach by Solans, Belén P., López‐Díaz de Cerio, Ascensión, Elizalde, Arlette, Pina, Luis Javier, Inogés, Susana, Espinós, Jaime, Salgado, Esteban, Mejías, Luis Daniel, Trocóniz, Iñaki F., Santisteban, Marta

“…Aims Immunotherapy is a rising alternative to traditional treatment in breast cancer (BC) patients in order to transform cold into hot immune enriched tumours…”
Get full text

C5a elevation in convalescents from severe COVID-19 is not associated with early complement activation markers C3bBbP or C4d by Kowalska, Daria, Kuźniewska, Alicja, Senent, Yaiza, Tavira, Beatriz, Inogés, Susana, López-Díaz de Cerio, Ascensión, Pio, Ruben, Okrój, Marcin, Yuste, José Ramón

“…Numerous publications have underlined the link between complement C5a and the clinical course of COVID-19. We previously reported that levels of C5a remain…”
Get full text

Immunologic characterization of COVID-19 patients with hematological cancer by Maia, Catarina, Martín-Sánchez, Esperanza, Garcés, Juan José, De Cerio, Ascensión López-Díaz, Inogés, Susana, Landecho, Manuel F, Gil-Alzugaray, Belén, Perez, Cristina, Botta, Cirino, Zabaleta, Aintzane, Alegre, Félix, Rincón, César, Blanco, Laura, Sarvide, Sarai, Vilas-Zornoza, Amaia, Alignani, Diego, Moreno, Cristina, Paiva, Artur, Martinho, António, Alves, Rui, Colado, Enrique, Quirós, Covadonga, Olid, Mónica, Blanco, Andrés, Argemi, Josepmaria, Paiva, Bruno, Yuste, José Ramón

Get full text

Maintenance therapy with ex vivo expanded lymphokine‐activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression by López‐Díaz de Cerio, Ascensión, García‐Muñoz, Ricardo, Pena, Esther, Panizo, Ángel, Feliu, Jesús, Giraldo, Pilar, Rodríguez‐Calvillo, Mercedes, Martínez‐Calle, Nicolás, Grande, Carlos, Olave, María T., Andrade‐Campos, Marcio, Bandrés, Eva, Núñez‐Córdoba, Jorge M., Inogés, Susana, Panizo, Carlos

“…Summary Anti‐cluster of differentiation 20 (CD20) monoclonal antibodies (mAbs) have shown promise in follicular lymphoma (FL) as post‐induction therapy, by…”
Get full text

Immunological Biomarkers of Fatal COVID-19: A Study of 868 Patients by Martín-Sánchez, Esperanza, Garcés, Juan José, Maia, Catarina, Inogés, Susana, López-Díaz de Cerio, Ascensión, Carmona-Torre, Francisco, Marin-Oto, Marta, Alegre, Félix, Molano, Elvira, Fernandez-Alonso, Mirian, Perez, Cristina, Botta, Cirino, Zabaleta, Aintzane, Alcaide, Ana Belen, Landecho, Manuel F, Rua, Marta, Pérez-Warnisher, Teresa, Blanco, Laura, Sarvide, Sarai, Vilas-Zornoza, Amaia, Alignani, Diego, Moreno, Cristina, Pineda, Iñigo, Sogbe, Miguel, Argemi, Josepmaria, Paiva, Bruno, Yuste, José Ramón

“…Information on the immunopathobiology of coronavirus disease 2019 (COVID-19) is rapidly increasing; however, there remains a need to identify immune features…”
Get full text

Idiotype vaccine production using hybridoma technology by Inoges, Susana, de Cerio, Ascensión López Díaz, Villanueva, Helena, Pastor, Fernando, Bendandi, Maurizio

“…Non-Hodgkin's lymphoma (NHL) is the most common hematological malignancy both in Europe and in the United States. Follicular lymphoma (FL), a tumor comprised…”
Get more information

Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins by Sarobe, Pablo, Lasarte, Juan José, Casares, Noelia, López-Díaz de Cerio, Ascensión, Baixeras, Elena, Labarga, Pablo, García, Nicolás, Borrás-Cuesta, Francisco, Prieto, Jesús

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma by Schalper, Kurt A., Rodriguez-Ruiz, Maria E., Diez-Valle, Ricardo, López-Janeiro, Alvaro, Porciuncula, Angelo, Idoate, Miguel A., Inogés, Susana, de Andrea, Carlos, López-Diaz de Cerio, Ascensión, Tejada, Sonia, Berraondo, Pedro, Villarroel-Espindola, Franz, Choi, Jungmin, Gúrpide, Alfonso, Giraldez, Miriam, Goicoechea, Iosune, Gallego Perez-Larraya, Jaime, Sanmamed, Miguel F., Perez-Gracia, Jose L., Melero, Ignacio

“…Glioblastoma is the most common primary central nervous system malignancy and has a poor prognosis. Standard first-line treatment, which includes surgery…”
Get full text

2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia by Soldevilla, Mario Martinez, Villanueva, Helena, Bendandi, Maurizio, Inoges, Susana, López-Díaz de Cerio, Ascensión, Pastor, Fernando

“…Abstract Recent studies have underscored the importance of immunomodulatory antibodies in the treatment of solid and hematological tumors. ODN-Aptamers are…”
Get full text

Targeting NK-cell checkpoints for cancer immunotherapy by Muntasell, Aura, Ochoa, Maria C, Cordeiro, Luna, Berraondo, Pedro, López-Díaz de Cerio, Ascension, Cabo, Mariona, López-Botet, Miguel, Melero, Ignacio

“…Highlights • NK cells are cytotoxic lymphocytes with potential for cancer immunotherapy. • NK-cell numbers and function are regulated by surface receptors and…”
Get full text

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study by Oliver-Caldés, Aina, González-Calle, Verónica, Cabañas, Valentín, Español-Rego, Marta, Rodríguez-Otero, Paula, Reguera, Juan Luis, López-Corral, Lucía, Martin-Antonio, Beatriz, Zabaleta, Aintzane, Inogés, Susana, Varea, Sara, Rosiñol, Laura, López-Díaz de Cerio, Ascensión, Tovar, Natalia, Jiménez, Raquel, López-Parra, Miriam, Rodríguez-Lobato, Luis Gerardo, Sánchez-Salinas, Andrés, Olesti, Eulàlia, Calvo-Orteu, Maria, Delgado, Julio, Pérez-Simón, José Antonio, Paiva, Bruno, Prósper, Felipe, Sáez-Peñataro, Joaquín, Juan, Manel, Moraleda, José M, Mateos, María-Victoria, Pascal, Mariona, Urbano-Ispizua, Alvaro, Fernández de Larrea, Carlos

“…Chimeric antigen receptor (CAR) T-cell therapy is a promising option for patients with heavily treated multiple myeloma. Point-of-care manufacturing can…”
Get full text

Imiquimod Enhances the Systemic Immunity Attained by Local Cryosurgery Destruction of Melanoma Lesions by Redondo, Pedro, del Olmo, Julio, López-Diaz de Cerio, Ascensión, Inoges, Susana, Marquina, Miren, Melero, Ignacio, Bendandi, Maurizio

“…Melanoma lesions can be frozen in vivo, resulting in necrotic death of malignant cells and in tumor antigen release suitable for cross-presentation by…”
Get full text

Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation by Bendandi, Maurizio, Rodríguez-Calvillo, Mercedes, Inogés, Susana, de Cerio, Ascensión López-Díaz, Pérez-Simón, José Antonio, Rodríguez-Caballero, Arancha, García-Montero, Andres, Almeida, Julia, Zabalegui, Natalia, Giraldo, Pilar, Miguel, Jesús San, Orfao, Alberto

“…Background and objective: To combine the use of idiotype-pulsed allogeneic dendritic cells (alloDC) and soluble protein Id conjugated with KLH (Id-KLH) in a…”
Get full text

Immunization with a tumor‐associated CTL epitope plus a tumor‐related or unrelated Th1 helper peptide elicits protective CTL immunity by Casares, Noelia, Lasarte, Juan José, Cerio, Ascensión López‐Díaz de, Sarobe, Pablo, Ruiz, Marta, Melero, Ignacio, Prieto, Jesús, Borrás‐Cuesta, Francisco

“…Immunization with cytotoxic T cell epitope SPSYVYHQF (AH1), derived from MuLV gp70 envelope protein expressed by CT26 tumor cells, does not protect BALB/c mice…”
Get full text

Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells by Ortiz de Landazuri, Iñaki, Oliver-Caldés, Aina, Español-Rego, Marta, Agulló, Cristina, Contreras, María Teresa, Zabaleta, Aintzane, Puig, Noemí, Cabañas, Valentín, González-Calle, Verónica, Zugasti, Inés, Inogés, Susana, Rodríguez Otero, Paula, Martin-Antonio, Beatriz, Reguera, Juan Luis, López-Diaz de Cerio, Ascensión, Aróstegui, Juan Ignacio, Uribe-Herranz, Mireia, Benítez-Ribas, Daniel, Rodríguez-Lobato, Luis Gerardo, González, Europa Azucena, Tovar, Natalia, Charry, Paola, Navarro, Sergio, Rosiñol, Laura, Tréboles, Karen, Mora, Génesis, Yagüe, Jordi, Moraleda, José María, Urbano-Ispizua, Álvaro, Mateos, María Victoria, Pascal, Mariona, Paiva, Bruno, Juan, Manel, Fernández de Larrea, Carlos

“…Chimeric antigen receptor (CAR) T-cell therapies have increased the patients with relapsed/refractory multiple myeloma (RRMM) in whom standard electrophoretic…”
Get full text

Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity by García-Muñoz, Ricardo, López-Díaz-de-Cerio, Ascensión, Feliu, Jesus, Panizo, Angel, Giraldo, Pilar, Rodríguez-Calvillo, Mercedes, Grande, Carlos, Pena, Esther, Olave, Mayte, Panizo, Carlos, Inogés, Susana

“…Follicular lymphoma (FL) is a disease of paradoxes—incurable but with a long natural history. We hypothesized that a combination of lymphokine-activated killer…”
Get full text

A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis by Rodriguez, Javier, Castañón, Eduardo, Perez-Gracia, Jose Luis, Rodriguez, Inmaculada, Viudez, Antonio, Alfaro, Carlos, Oñate, Carmen, Perez, Guiomar, Rotellar, Fernando, Inogés, Susana, López-Diaz de Cerio, Ascensión, Resano, Leyre, Ponz-Sarvise, Mariano, Rodriguez-Ruiz, Maria E, Chopitea, Ana, Vera, Ruth, Melero, Ignacio

“…Surgically resectable synchronic and metachronic liver metastases of colon cancer have high risk of relapse in spite of standard-of-care neoadjuvant and…”
Get full text

Variations in “rescuability” of immunoglobulin molecules from different forms of human lymphoma: implications for anti-idiotype vaccine development by Rodrı́guez-Calvillo, Mercedes, Inogés, Susana, López-Dı́az de Cerio, Ascensión, Zabalegui, Natalia, Villanueva, Helena, Bendandi, Maurizio

“…Idiotypic (Id) vaccination has shown promising results in patients with follicular lymphoma (FL). However, it still remains unclear whether the same approach…”
Get full text